Zacks Investment Research on MSN
GE HealthCare wins FDA clearances for next-gen SIGNA MRI portfolio
GE HealthCare Technologies Inc. GEHC recently announced FDA 510(k) clearance for three new magnetic resonance (MR) innovations — SIGNA Sprint with Freelium, a 1.5T sealed magnet MRI system; SIGNA Bolt ...
SIGNA Sprint with Freelium, a new 1.5T sealed magnet MRI system, combines a sustainable design with uncompromised image quality, and operational autonomy to expand access to advanced MR, even in ...
The FDA clearance of GE HealthCare’s next-generation Signa products aligns with the company’s multi-year strategy to differentiate its MRI portfolio.
Freelium, a helium-free i sealed magnet platform in development, aims to dramatically reduce liquid helium usage without sacrificing power efficiency, operational security and clinical performance ...
CHICAGO--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC) today announced the 510(k) submissions to the U.S. Food and Drug Administration (FDA) seeking clearance for next-generation SIGNA™ MRI ...
New MRI technology aims to advance neuroimaging and biomarker research CHICAGO--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC) has received FDA 510(k) clearance for its innovative SIGNA™ MAGNUS,i a ...
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced the FDA clearance and launch of Sonic DL – a state-of-the-art deep learning-based technology designed to dramatically accelerate ...
The FDA cleared the Signa Sprint with Freelium, Signa Bolt and Signa One. Signa Sprint is a 1.5T sealed magnet MRI system, ...
GE HealthCare GEHC recently unveiled its next-generation SIGNA MRI portfolio, the 3T SIGNA Bolt and 1.5T SIGNA Sprint with Freelium, aimed at boosting efficiency, advancing precision diagnostics and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results